The GAVI effect: How the GAVI Alliance works to protect children from preventable diseases

http://www.gavialliance.org/media_centre/videos/iffim_video.php

The GAVI effect: How the GAVI Alliance works to protect children from preventable diseases

“… this is entirely different – we are not here asking for charity or philanthropy, we are here with an investment proposition.

Dr Alan Gillespie, IFFIm Chairperson

Vaccine Investment

Make a fixed return, make a real difference When interest rates fall and markets are uncertain, investors look for new ways to make solid returns. Suddenly, cautious investments seem more attractive. Sadly, in times like these, humanitarian causes can get overlooked. So a cautious investment that offers tangible human benefits and is designed to provide financial returns? That’s an interesting proposition.

Every £1,000 you invest will help immunise over 130 children against five life—threatening diseases*

The Vaccine Investment Plan and Vaccine Investment ISA are the first of their kind in the UK. Recent changes to ISA regulations have allowed institutions who receive contributions for international humanitarian development projects to issue bonds and other securities that are now capable of being held within an ISA.

This investment aims to provide a competitive, fixed return of 16.2%, together with your original capital repaid in full. To enjoy the full return you will need to keep your investment until the end of the 5 year 1 month term. Withdrawing early may mean you get back significantly less than your original investment.

Whilst the investment aims to provide a fixed return at the end of the fixed investment term, you should understand that this is not guaranteed. Please read the Key Features Document (PDF) to understand more about the benefits and risks of the plan.

HSBC has worked closely with the International Finance Facility for Immunisation (IFFIm), the GAVI Alliance (formerly the Global Alliance for Vaccines and Immunisation) and the World Bank, to be able to offer investors a unique opportunity.

You can now help to accelerate immunisation programmes for children in some of the world’s poorest countries and, at the same time, enjoy tax—efficient returns. You can make a sound investment that could reap both financial and human benefits.

*Diptheria, Tetanus, Pertussis (Whooping cough), Hepatitis B and Haemophilus Influenzae type b (Hib). Source: GAVI Alliance 2009

About the author

VT

Jeffry John Aufderheide is the father of a child injured as a result of vaccination. As editor of the website www.vactruth.com he promotes well-educated pediatricians, informed consent, and full disclosure and accountability of adverse reactions to vaccines.